Apoptosis and apoptosis-related molecules in the submandibular gland of the nonobese diabetic mouse model for Sjögren's syndrome: Limited role for apoptosis in the development of sialoadenitis

Laboratory Investigation

Volumn 83, Issue 1, 2003, Pages 3-11

  Van Blokland, Saskia C A ^a   Van Helden Meeuwsen, Cornelia G ^a   Wierenga Wolf, Annet F ^a   Tielemans, Dennis ^a   Drexhage, Hemmo A ^a   Van de Merwe, Joop P ^a   Homo Delarche, Françoise ^b   Versnel, Marjan A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE COURSE; EPITHELIUM CELL; EXOCRINE GLAND; FEMALE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIALOADENITIS; SJOEGREN SYNDROME; STRAIN IDENTIFICATION; SUBMANDIBULAR GLAND;

EID: 0037239370     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000048721.21475.D1     Document Type: Article

References (37)

1. Aziz KE, Montanaro A, McCluskey PJ, and Wakefield D (1992). Sjögren's syndrome: review with recent insights into immunopathogenesis. Austr N Z J Med 22:671-678.
2. Banchereau J and Steinman RM (1998). Dendritic cells and the control of immunity. Nature 392:245-252.
3. Cella M, Sallusto F, and Lanzavecchia A (1997). Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10-16.
4. Cha S, Van Blokland SCA, Versnel MA, Homo-Delarche F, Nagashima H, Brayer J, Peck AB, and Humphreys-Beher MG (2001). Abnormal organogenesis in salivary gland development may initiate adult onset of autoimmune exocrinopathy. Exp Clin Immunogenet 18:143-160.
5. Elkon KB (1998). Fas (APO-1/CD95)-assisted suicide in NOD exocrine glands. Clin Exp Rheumatol 16:659-661.
6. Fox RI (1995). Sjögren's syndrome. Curr Opin Rheumatol 7:409-416.
7. Fox RI (1996). Clinical features, pathogenesis, and treatment of Sjögren's syndrome. Curr Opin Rheumatol 8:438-445.
8. Green DR and Scott DW (1994). Activation-induced apoptosis in lymphocytes. Curr Opin Immunol 6:476-487.
9. Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, Noji S, Sugino H, and Hayashi Y (1997). Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science 276:604-607.
10. Humphreys-Beher MG (1996). Animal models for autoimmune disease-associated xerostomia and xerophthalmia. Adv Dent Res 10:73-75.
11. Humphreys-Beher MG, Hu Y, Nakagawa Y, Wang PL, and Purushotham KR (1994). Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjogren's syndrome. Adv Exp Med Biol 350:631-636.
12. Humphreys-Beher MG, Peck AB, Dang H, and Talal N (1999). The role of apoptosis in the initiation of the autoimmune response in Sjogren's syndrome. Clin Exp Immunol 116:383-387.
13. Ishii KJ, Suzuki K, Coban C, Takeshita F, Itoh Y, Matoba H, Kohn LD, and Klinman DM (2001). Genomic DNA released by dying cells induces the maturation of APCs. J Immunol 167:2602-2607.
14. Kong L, Ogawa N, McGuff HS, Nakabayashi T, Sakata KM, Masago R, Vela-Roch N, Talal N, and Dang H (1998a). Bcl-2 family expression in salivary glands from patients with primary Sjogren's syndrome: Involvement of Bax in salivary gland destruction. Clin Immunol Immunopathol 88:133-141.
15. Kong L, Ogawa N, Nakabayashi T, Liu GT, E DS, McGuff HS, Guerrero D, Talal N, and Dang H (1997). Fas and Fas ligand expression in the salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum 40:87-97.
16. Kong L, Robinson CP, Peck AB, Vela-Roch N, Sakata KM, Dang H, Talal N, and Humphreys-Beher MG (1998b). Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice. Clin Exp Rheumatol 16:675-681.
17. Labat-Moleur F, Guillermet C, Lorimier P, Robert C, Lantuejoul S, Brambilla E, and Negoescu A (1998). TUNEL apoptotic cell detection in tissue sections: critical evaluation and improvement critical evaluation and improvement. J Histochem Cytochem 46:327-334.
18. Manganelli P, Quaini F, Andreoli AM, Lagrasta C, Pilato FP, Zuccarelli A, Monteverdi R, D'Aversa C, and Olivetti G (1997). Quantitative analysis of apoptosis and bcl-2 in Sjogren's syndrome. J Rheumatol 24:1552-1557.
19. Martin SJ, O'Brien GA, Nishioka WK, McGahon AJ, Mahboubi A, Saido TC, and Green DR (1995). Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem 270:6425-6428.
20. Matsumura R, Umemiya K, Kagami M, Tomioka H, Tanabe E, Sugiyama T, Sueishi M, Nakajima A, Azuma M, Okumura K, and Sumida T (1998). Glandular and extraglandular expression of the Fas-Fas ligand and apoptosis in patients with Sjogren's syndrome. Clin Exp Rheumatol 16:561-568.
21. Mevorach D, Zhou JL, Song X, and Elkon KB (1998). Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 188:387-392.
22. Nagata S (1997). Apoptosis by death factor. Cell 88:355-365.
23. Negoescu A, Lorimier P, Labat-Moleur F, Drouet C, Robert C, Guillermet C, Brambilla C, and Brambilla E (1996). In situ apoptotic cell labeling by the TUNEL method: Improvement and evaluation on cell preparations. J Histochem Cytochem 44:959-968.
24. Ohlsson M, Skarstein K, Bolstad AI, Johannessen AC, and Jonsson R (2001). Fas-induced apoptosis is a rare event in Sjogren's syndrome. Lab Invest 81:95-105.
25. Robinson CP, Yamamoto H, Peck AB, and Humphreys-Beher MG (1996). Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: A potential trigger for sialoadenitis of NOD mice. Clin Immunol Immunopathol 79:50-59.
26. Rosen A and Casciola-Rosen L (1999). Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 6:6-12.
27. Rosen A and Casciola-Rosen L (2001). Clearing the way to mechanisms of autoimmunity. Nat Med 7:664-665.
28. Rovere P, Vallinoto C, Bondanza A, Crosti MC, Rescigno M, Ricciardi-Castagnoli P, Rugarli C, and Manfredi AA (1998). Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol 161:4467-4471.
29. Rudin CM and Thompson CB (1997). Apoptosis and disease: Regulation and clinical relevance of programmed cell death. Annu Rev Med 48:267-281.
30. Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL, Earp HS, and Matsushima GK (2001). Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411:207-211.
31. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL, and Leiter EH (1995). Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 154:180-191.
32. Stingl G and Bergstresser PR (1995). Dendritic cells: A major story unfolds. Immunol Today 16:330-333.
33. Thompson CB (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
34. Vanags DM, Porn-Ares MI, Coppola S, Burgess DH, and Orrenius S (1996). Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem 271:31075-31085.
35. van Blokland SCA, van Helden-Meeuwsen CG, Wierenga-Wolf AF, Drexhage HA, Hooijkaas H, van de Merwe JP, and Versnel MA (2000). Two different types of sialoadenitis in the NOD- and MRL/lpr mouse models for Sjögren's syndrome: A differential role for dendritic cells in the initiation of sialoadenitis? Lab Invest 80:575-585.
36. Wang J and Lenardo MJ (1997). Molecules involved in cell death and peripheral tolerance. Curr Opin Immunol 9:818-825.
37. Watanabe T, Tsuchida T, Kanda N, Mori K, Hayashi Y, and Tamaki K (1999). Anti-alpha-fodrin antibodies in Sjogren syndrome and lupus erythematosus. Arch Dermatol 135:535-539.